Leaderboard

En | De
No articles selected!     View Cart  
You are here: Neurology » Alzheimer 30. October 2026
Search
medline.ch
Alzheimer
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Alzheimer
Epilepsy
Infections
Headache
Multiple Sclerosis
Neoplasms
Neuromuscular Diseases
Parkinson
Cerebrovascular Diseases
CNS Trauma
Others
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 3649  Previews Next
   
   Articles 1 - 20 / 72964  
   
The impact of structural variation on Alzheimer's disease in the Alzheimer's disease sequencing project.
Genome Biol
Lee S, English AC, Peloso GM, Bis JC, Boerwinkle E, Choi SH, Heard-Costa NL, Lin H, Xia R, Seshadri S, Destefano AL, Fornage M, Sedlazeck FJ.
PMID: 42958586 [PubMed - indexed for MEDLINE]


Neuropathological and vascular determinants of cerebral amyloid angiopathy risk: evidence from the NACC cohort.
Alzheimers Res Ther
Ma L, Wang Y, Goudey B, Jin L, Pan Y.
PMID: 42958434 [PubMed - indexed for MEDLINE]


A prospective observational study measuring the stability of plasma pTau181 using the Elecsys Phospho-Tau (181P) plasma immunoassay for early detection of Alzheimer's disease.
Alzheimers Res Ther
Kurz C, Leonhardt S, Hufnagel A, Wizemann S, Deutelmoser H, Menzel P, Perneczky R.
PMID: 42958309 [PubMed - indexed for MEDLINE]


Effects of motion and white matter hyperintensities on reference region based ¹�F-SynVesT-1 PET quantification in Alzheimer's disease and healthy volunteers.
EJNMMI Res
Carron C, Noë S, Vanderlinden G, Koole M, Schramm G, Van Laere K.
PMID: 42957873 [PubMed]


Glymphatic Dysfunction as a Multisystem Pathway Linking Systemic Health Conditions to Alzheimer's Disease: Mechanisms, Risk Factors, and Therapeutic Opportunities.
Mol Neurobiol
Abaresh S, Ivantsova E, Parmar MS.
PMID: 42957838 [PubMed - indexed for MEDLINE]


Artificial intelligence applications in microbiota-gut-brain axis research: Implications for Alzheimer's disease.
J Alzheimers Dis
Lista S, Emanuele E, Cuperlovic-Culf M, Mahdi A, Singh V, López-Ortiz S, Khoramipour K, Merino-País M, Minoretti P, Cisale GY, Heslegrave A, Imbimbo C, Sancesario GM, Bendlin BB, Imbimbo BP, Zetterberg H, Santos-Lozano A.
PMID: 42957639 [PubMed - as supplied by publisher]


Improving the Diagnostic Accuracy of Plasma Alzheimer's Disease Biomarkers With Objective and Subjective Cognitive Screening.
Ann Clin Transl Neurol
Abdolmaleki M, Gaynor LS, Liu D, Hohman TJ, Gifford KA, Zetterberg H, Jefferson AL, Bolton CJ.
PMID: 42957617 [PubMed - as supplied by publisher]


The Effects of Virtual Reality Group Reminiscence Therapy on Agitation, Cognition, Depression and Social Function in Patients With Alzheimer's Disease.
Psychogeriatrics
Chen D, Wang H, Su C, Lv S, He M, Li N.
PMID: 42957174 [PubMed - indexed for MEDLINE]


Selective neuronal vulnerability in Alzheimer's disease: mechanisms, biomarkers, and therapeutic implications.
Ageing Res Rev
Tian-Yang X, Er-Deng E, Ting Z, Xiao-Qin Z.
PMID: 42956845 [PubMed - as supplied by publisher]


Wnt/β-catenin signaling dysregulation in Alzheimer's disease and therapeutic opportunities.
Biomed Pharmacother
Alkhalifa AE, Al-Ghraiybah NF, Al-Gharaibeh AF, Kaddoumi A.
PMID: 42956527 [PubMed - as supplied by publisher]


Towards improving Alzheimer's intervention: a machine learning approach for biomarker detection through combining MEG and MRI pipelines.
J Neural Eng
Ahmad AL, Sánchez-Bornot JM, Sotero RC, Coyle DH, Idris Z, Faye I.
PMID: 42956415 [PubMed - as supplied by publisher]


Understanding Glymphatic's Role In Proteinopathies (GRIP): A single centre case-control study protocol.
PLoS One
Lian SL, Storås TH, Gløersen EM, Løvland G, Hopp E, Mossige I, Hovd M, Uggerud HT, Kardel KR, Bye HA, Buset AL, Valdmanis K, Knapskog AB, Øksengård AR, Fladby T, Nilsen KB, Mardal KA, Ringstad G, Eide PK, Toft M, Nordengen K.
PMID: 42956044 [PubMed - indexed for MEDLINE]


Unraveling the role of CARM1 in Alzheimer's disease: molecular mechanisms and therapeutic potential.
Inflammopharmacology
Gupta SK, Aran KR.
PMID: 42955508 [PubMed - as supplied by publisher]


Super-Cross-Reactive Recognition Enables Preclinical Diagnosis of Alzheimer's Disease.
J Am Chem Soc
Li WB, Li J, Ning XY, Tian JH, Chen FY, Zhang SX, Wang ZH, Pan YC, Zhang W, Guo DS.
PMID: 42954557 [PubMed - indexed for MEDLINE]


A general practice-centred model for early diagnosis and management of Alzheimer's disease in Denmark: rationale, evidence and a pragmatic diagnostic approach.
Scand J Prim Health Care
Kjær NK, Lykkegaard J, Ibsen H, Llor C, Søndergaard J.
PMID: 42954299 [PubMed - indexed for MEDLINE]


TREM2 Signaling and Alzheimer's Disease: Experimental Modulators, Progress, and Challenges.
Drug Des Devel Ther
Sayegh M, Azarfar K, Reyna EM, Kennedy JM, Sabbagh MN, Decourt B.
PMID: 42953588 [PubMed - indexed for MEDLINE]


Advances in artificial intelligence-driven MRI research in Alzheimer's disease.
Front Neurol
Deng L, Zeng Y, Ou P, Zhou S, Gou Y, Huang C.
PMID: 42953191 [PubMed - indexed for MEDLINE]


Luteolin for Alzheimer's disease and related cognitive impairment: a systematic review and meta-analysis of efficacy and molecular mechanisms.
Front Med (Lausanne)
Xin J, Teng X, Su H, Wang X, Li M.
PMID: 42953065 [PubMed]


Grey matter atrophy signatures and their genetic associations: a trans-disease study of Alzheimer's disease and multiple sclerosis.
Front Neuroimaging
Zhao Y, Sun J, Reheman B, Bai X, Zhang C, Ding W, Zou B, Zhang H, Zhang Z, Zhang N.
PMID: 42952837 [PubMed]


Family hardiness and associated factors among Chinese family caregivers of people with Alzheimer's disease: an explanatory sequential mixed-methods study.
Front Psychol
Lan X, Xia M, Chen L, Zheng S, Jin L, Wang Y, Lu S, Xu J, Xu L, Li C, Yan P.
PMID: 42952769 [PubMed]


   
   Articles 1 - 20 / 72964    Page 1 of 3649  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1